| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/18/2005 | US6844446 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 01/18/2005 | US6844363 Storage stability; drugs; influenza therapy |
| 01/18/2005 | US6844309 Ether-capped poly(oxyalkylated) alcohol surfactants |
| 01/13/2005 | US20050009997 Novel chiral auxiliary bearing resins |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009706 Herbicides; plant safening agents |
| 01/12/2005 | EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 01/12/2005 | EP1259502B1 Biologically active analogs of discodermolide |
| 01/12/2005 | CN1184214C Alpha-acyl and alpha-heteroatom-bustituted benzene acetamide glucokinase activators |
| 01/11/2005 | US6841703 Polymerization of ethylenically unsaturated monomers with low dispersity |
| 01/06/2005 | WO2005000822A1 N-{‘4-substituted piperazine-1-sulfonylmethyl!alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | US20050004215 Dihydroxy open acid form; solubility, bioavailability |
| 01/06/2005 | US20050004210 Process for producing a pyran compound |
| 01/06/2005 | US20050004093 Using 6-betahydroxymethylpenicillanic acid sulfone; bactericides; therapy for bacteria infections in mammals |
| 01/06/2005 | US20050003499 Using microfiltration to remove cellular debris and isolate statins form mycelial fermentation broth; anticholesteriol agents for treatment and prevention of cardiovascular diseases |
| 01/06/2005 | CA2529468A1 N-{[4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1493814A1 Cell-free synthesis of polyketides |
| 01/05/2005 | EP1493737A1 Process for producing a pyran compound |
| 01/05/2005 | EP1492753A1 Process for converting alcohols to carbonyl compounds |
| 01/05/2005 | EP1492539A1 Statin therapy for enhancing cognitive maintenance |
| 01/05/2005 | CN1561333A Aromatic and heteroaromatic acid halides for synthesizing polyamides |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561326A Alpha-haloenamine reagents |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/04/2005 | US6838566 Salts of HMG-CoA reductase inhibitors |
| 12/30/2004 | US20040267044 Process for preparing simvastatin having controlled ranges of simvastatin dimer content |
| 12/29/2004 | WO2004113312A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 12/29/2004 | EP1490350A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 12/29/2004 | EP1490328A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation |
| 12/29/2004 | EP1490173A2 Metalorganic catalysts for chemo-, regio- and stereoselective reactions, and corresponding precursors |
| 12/29/2004 | EP1490058A1 Peroxisome proliferator activated receptor modulators |
| 12/29/2004 | EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators |
| 12/29/2004 | EP1206442A4 Substituted chiral allosteric hemoglobin modifiers |
| 12/29/2004 | EP0836649B1 Cell-free synthesis of polyketides |
| 12/29/2004 | CN1558897A Antidiabetic agents |
| 12/29/2004 | CA2528317A1 Hydroxamate sulfonamides as cd23 shedding inhibitors |
| 12/28/2004 | US6835841 Asymmetric catalytic hydrogenation process for preparation of chiral cyclic β-aminoesters |
| 12/23/2004 | WO2004111255A1 Ion-exchange filtration of fermentation broth |
| 12/23/2004 | WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 12/23/2004 | WO2003095438A9 Substituted phenylacetamides and their use as glucokinase activators |
| 12/23/2004 | US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 12/22/2004 | EP1487814A1 Process for the preparation of 4-oxytetrahydropyran-2-ones |
| 12/22/2004 | EP1487812A1 Anomeric derivatives of monosaccharides |
| 12/22/2004 | EP1086076B1 Sulfonamide inhibitors of aspartyl protease |
| 12/21/2004 | US6833461 Process for preparing simvastatin |
| 12/21/2004 | US6833367 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 12/16/2004 | WO2004108733A1 Beta-lactamase inhibitor prodrug |
| 12/16/2004 | WO2003063797A8 Cycloalkyl inhibitors of potassium channel function |
| 12/16/2004 | DE102004025809A1 4-(tetrahydropyran-2-yl)-1-substituted-terphenyl liquid crystal compounds used in liquid crystal medium for electrooptical purposes, especially in matrix, in-plane switching and twisted and supertwisted nematic displays are new |
| 12/16/2004 | CA2528065A1 Beta-lactamase inhibitor prodrug |
| 12/16/2004 | CA2527989A1 Glycyrrhizin or derivatives thereof for treating or preventing severe acute respiratory syndrome (sars) |
| 12/15/2004 | EP1485377A1 Pyranones useful as atm inhibitors |
| 12/15/2004 | EP1485089A1 Combination treatments for chemokine-mediated diseases |
| 12/15/2004 | EP1117639B1 Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators |
| 12/15/2004 | EP1088844B1 Polyamide and process for producing the same |
| 12/15/2004 | EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 12/15/2004 | CN1555351A Method for the preparation of unsaturated hydroxy fatty acids and their esters, their use in pharmaceutical and/or cosmetic preparations |
| 12/15/2004 | CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them |
| 12/14/2004 | US6831193 Trisubstituted-N-[(1S)-1,2,3,4-Tetrahydro-1-naphthalenyl]benzamides which inhibit P2X3 and P2X2/3 containing receptors |
| 12/14/2004 | US6831180 Substituted tertiary carboxylic oxacycloalkane acids, used to prepare anhydro-homo-harringtonic acids by semi-synthesis; hydroxyl function of a cephalotaxane is esterified with a 2-carboxyl-2-alkyl-1-oxacycloalkane claimed intermediate; (indexing from 7169774 added) |
| 12/09/2004 | WO2004106460A1 Liquid-crystalline compounds having a tetrahydropyran ring |
| 12/09/2004 | WO2004106320A1 Process for producing optically active lactone |
| 12/09/2004 | WO2004106319A1 Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide |
| 12/09/2004 | WO2004106269A1 Method for producing substituted shiral diols and diol-analogous derivatives |
| 12/09/2004 | US20040249220 Process for producing optically active 2-alkoxy-1-(trifluoromethyl-substituted phenyl) ethanol derivatives |
| 12/08/2004 | EP1484317A1 Lactic acid derivative |
| 12/08/2004 | EP1483248A1 Halobenzyl substituted phenylaceto esters and amides and use thereof for prevention of harmful organisms |
| 12/08/2004 | EP1483241A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 12/08/2004 | EP1483236A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists |
| 12/08/2004 | EP1114040B1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 12/08/2004 | EP0966420B1 2-arylcyclopentane-1,3-diones |
| 12/08/2004 | CN1178927C Histamine H3 receptor ligands |
| 12/08/2004 | CN1178915C Alkynyl containing hydroxamic acid derivatives and its preparation and its use as matrix metalloproteinase (MMP) inhibitors/TNF-alpha converting enzyme (TACE) inhibitors |
| 12/08/2004 | CN1178906C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 12/07/2004 | US6827876 Using alpha, alpha -difluorocyclohexylidene derivative as starting material to obtain difluoromethyl ether derivative |
| 12/02/2004 | WO2004103951A1 Method for producing an optically active nitro compound |
| 12/02/2004 | WO2004103950A1 Novel partially protected trisphenols and process for the preparation thereof |
| 12/02/2004 | WO2004072031A3 Phenylacetamides and their use as glucokinase modulators |
| 12/02/2004 | WO2004071456A3 Process for preparing simvastatin having controlled ranges of simvastatin dimer content |
| 12/02/2004 | US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis |
| 12/02/2004 | US20040242574 Anticancer agents; antiarthritic agents |
| 12/01/2004 | EP1482022A1 Pyrans as liquid crystals |
| 12/01/2004 | EP1482020A1 Pyran derivatives with an exocyclic double bond |
| 12/01/2004 | EP1482019A1 Pyran derivatives |
| 12/01/2004 | EP1481970A1 Novel herbicides |
| 12/01/2004 | EP1480966A1 Compounds and methods of treating cell proliferative diseases |
| 12/01/2004 | EP1480965A1 Method for purifying simvastatin |
| 12/01/2004 | EP1480944A2 Substituted aryl ketones |
| 12/01/2004 | EP1423385A4 Intermediates for preparing neuraminidase inhibitor conjugates |
| 12/01/2004 | EP1055671B1 A process for producing a simvastatin precursor |
| 12/01/2004 | EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds |
| 12/01/2004 | CN1177821C Matrix metalloprotease inhibitors |
| 11/30/2004 | US6825362 Process for lactonization to produce highly pure simvastatin |
| 11/30/2004 | US6825354 Osteoporosis; rheumatic diseases |
| 11/30/2004 | US6825015 Process for the obtaining of HMG-COA reductase inhibitors of high purity |
| 11/25/2004 | WO2004101508A2 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 11/25/2004 | WO2004067489A3 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 11/25/2004 | US20040235939 Macrolactone having very dense functionalization; antiproliferative activity |